Skip to main content
Premium Trial:

Request an Annual Quote

Macrogen Named Roche NimbleGen CSP

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche NimbleGen today said that it has named Macrogen a Certified Service Provider for Korea.

Specifically, Macrogen has joined the CSP program for offering services using NimbleGen's Comparative Genomic Hybridization/Copy Number Variation services in its lab in Seoul, South Korea. Macrogen will process gDNA samples for CGH/CNV using the complete NimbleGen array CGH workflow including the high-resolution MS 200 Microarray Scanner.

Macrogen had used the NimbleGen aCGH microarrays as part of its efforts for the Korea Centers for Disease Control and Prevention's CNV projects. That project was a two-phase study, which included a large-scale characterization of CNVs in Korean populations and analysis of common CNVs in genome-wide association studies for 6,000 Korean individuals, said Roche in a statement.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.